AzTrials
AzTrials

HIV PreventionNCT05804461

Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico

A study testing Motivational Interviewing in people with HIV Prevention, run by University of Puerto Rico at 1 site in Puerto Rico.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

To develop, assess and compare the effectiveness of a Motivational Interviewing Intervention for increasing Pre-Exposure Prophylaxis (PrEP) uptake among Latino eligible men in Puerto Rico. Read more about this study

Who is it for?
Ages 21 to 99 years, men onlyHealthy volunteers can take part
Conditions the study is for
HIV Prevention
What is being tested?
Motivational Interviewing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
182 participants
Where
1 sitePuerto Rico
Study dates
1 Sep 2023to 31 May 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 99 years
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • HIV positive individual
  • Evidence of being under the effects of alcohol or drugs
  • Indication of unstable or serious psychiatric symptoms
  • Evidence of major cognitive impairment
  • Inability to speak and read in Spanish
  • Healthcare Providers group - Inclusion Criteria:
Show all 13Show fewer
  • Age 21 or older
  • Providing PrEP related health services at time of enrollment (e.g., case management, clinical services)
  • Spanish fluency (ability to write and read in Spanish)
  • Evidence of being under the effects of alcohol or drugs
  • Indication of unstable or serious psychiatric symptoms
  • Evidence of major cognitive impairment
  • Inability to speak and read in Spanish

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Puerto Rico1 site, 1 recruiting
  • University of Puerto Rico Medical Sciences Campus

    San Juan, 00936

    Souhail M Malave Rivera, PhD, 787 758 2525 ext. 4412, souhail.malave@upr.edu

    Recruiting

Other trials in Puerto Rico

About this study

Official title: Optimizing PrEP Uptake Among Latino MSM in Puerto Rico: A Comparative Effectiveness Study

To develop, assess and compare the effectiveness of a Motivational Interviewing Intervention for increasing Pre-Exposure Prophylaxis (PrEP) uptake among Latino eligible men in Puerto Rico.

Conditions
HIV Prevention
Being tested
Motivational Interviewing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational InterviewingBehavioural

    Upon refinement from Formative Research (Aim 1), a three-session, individual-level intervention to increase Pre-Exposure Prophylaxis (PrEP) uptake among men who have sex with men (MSM) in Puerto Rico will be implemented. The facilitator will use Motivational Interviewing techniques to guide the sessions. The intervention's design and content will be the same for each study group; the only difference will be the modality of implementation; one group of participants will receive a face-to-face intervention, while another group will receive an online intervention.A total of 170 participants will be randomized in a 1:1 ratio into each of the two intervention modalities (n=85 face-to-face and n=85 online) while a control group will be recruited following a 3:1 ratio of intervention vs. control. In addition to baseline assessment, participants will be asked to complete a post test at the end of the third session (60 days) and a follow-up post-test at the 150-day mark, separately.

Study groups in NCT05804461
Study groupRoleWhat they receive
Face-to-face interventionExperimentalA three-session face-to-face intervention using Motivational Interviewing with a facilitator; to increase Pre-Exposure Prophylaxis (PrEP) uptake. Pre-post-post evaluations after each session will be administered. Participation will last 150 days from the start to the last follow-up.
Receives: Behavioral: Motivational Interviewing
Online interventionExperimentalA three-session online intervention using Motivational Interviewing with a facilitator; to increase Pre-Exposure Prophylaxis (PrEP) uptake. Pre-post-post evaluations after each session will be administered. Participation will last 150 days from the start to the last follow-up.
Receives: Behavioral: Motivational Interviewing
ControlNo interventionNo intervention. Pre-post evaluations will be administered.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary

    PrEP uptake

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2023
  2. Study start1 Sep 2023
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
182 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05804461
Sponsor's protocol ID
2290030276
Status last verified
Jul 2026
First submitted
27 Mar 2023
Last updated
15 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in